| Financial Year |
March 31 2023 |
| Monetary Funds |
671,617,702.89 |
| Held-for-trading Financial Assets |
2,146,240,000.00 |
| Notes Receivable |
16,998,863.04 |
| Accounts Receivable |
601,015,163.96 |
| Advances to Suppliers |
15,468,295.69 |
| Other Receivables |
142,562,303.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,281,316.70 |
| Dividend Receivable |
-- |
| Inventories |
108,290,914.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,081,002.38 |
| Total Current Assets |
3,745,364,746.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,362,045,008.17 |
| Investment Properties |
-- |
| Fixed Assetes |
6,325,058,296.36 |
| Under-construction Projects |
2,364,117,180.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
496,197,286.06 |
| R&D expenses |
2,220,351.24 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,355,456.04 |
| Deferred Income Tax Assets |
73,938,482.40 |
| Other Non-Current Assets |
370,105,065.88 |
| Sub-Total of Non-Current Assets |
55,438,540,332.90 |
| Total Assets |
59,183,905,078.98 |
| Short-Term Loans |
2,422,004,962.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,405,816.24 |
| Accounts Payable |
146,954,738.10 |
| Accounts Received In Advance |
706,163.75 |
| Employee Compensation Payable |
177,724,220.58 |
| Taxes Payable |
125,158,916.82 |
| Interest Payable |
24,456,739.52 |
| Dividend Payable |
71,370,051.46 |
| Other payables |
918,169,888.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,064,625,387.76 |
| Other Current Liabilities |
2,033,939,757.39 |
| Sub-Total of Current Liabilities |
6,907,168,296.56 |
| Long-term Loans |
5,566,593,828.37 |
| Bonds Payable |
6,773,101,139.98 |
| Long-Term Accounts Payable |
2,931,731,128.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
30,993,967.69 |
| Deferred Income Tax Liabilities |
283,591,976.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,998,951,631.27 |
| Total Liabilities |
22,906,119,927.83 |
| Paid-In Capital(Or Share Stock) |
4,460,608,261.00 |
| Capital Surplus |
4,572,651,092.10 |
| Surplus Reserve |
8,369,379,743.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
15,576,632,731.48 |
| Minority Stockholder's Interest |
1,392,804,566.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
34,884,980,584.94 |
| Owner's Equity（Stockholder's Equity） |
36,277,785,151.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
59,183,905,078.98 |
